Clinical Trial

Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations

Study acronym: ITACA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 28, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators hypothesize that cardiovascular and metabolic alterations can occur in patients with adrenal adenomas and possible Autonomous Cortisol Secretion (pACS). Investigators hypothesize that adrenalectomy in selected patients, following the 2016 European Congress of Endocrinology (ECE) guidelines, can improve metabolic parameters and cardiovascular risks and features.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-10-11; most recent amendment 2025-03-24.
Trial Details
NCT Number NCT04127552
Lead Sponsor University of Roma La Sapienza
Conditions Adrenal Incidentaloma, Hypercortisolism, Adrenal Tumor
Enrollment 68 participants
Start Date 2019-01-02
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-28